Disclosed herein are methods of detecting a target nucleic acid in a sample (e.g., biological sample or environmental sample). The method includes administering to the sample an effective amount of a composition comprising an engineered bacterium (e.g., A. baylyi) and detecting an output signal. In some cases, the mammal has a cancer or an infectious disease.
US20250027168A1Provided herein are methods for generating multiplex CRISPR arrays based on annealing and ligating single-stranded DNA oligonucleotides using bridge oligonucleotides. The methods described herein include providing a first oligonucleotide comprising a CRISPR repeat sequence or a portion thereof, and a first portion of a first spacer sequence at its 3′ end; providing a second oligonucleotide comprising, from 5′ to 3′, a second portion of the first spacer sequence, the CRISPR repeat sequence, and a first portion of a second spacer sequence; providing a bridge oligonucleotide comprising a sequence substantially complementary to the first spacer sequence; allowing the first oligonucleotide and the second oligonucleotide to hybridize with the bridge oligonucleotide; and ligating the first and second oligonucleotide.
US20240141399A1